Zusammenfassung
Die Langzeitprognose ist in der Regel bei zystischen Pankreasläsionen (inklusive der malignen Tumoren) deutlich besser als bei duktalen Adenokarzinomen einzustufen. Dennoch unterscheidet sich die individuelle Prognose stark – abhängig von dem jeweilig zugrundeliegenden histologischen Subtyp. Aufgrund der höheren Entartungsrate der Hauptgang-IPMN finden sich die Rezidive auch überwiegend bei diesem Subtyp (ca. 60–80 %). Die Langzeitüberlebensraten korrelieren eng mit dem Nachweis invasiver Areale und sind in diesem Falle deutlich kürzer als bei Patienten ohne Malignitätsnachweis. Bei den muzinösen Zystadenomen hängt die Prognose direkt von einem evtl. Nachweis invasiver Areale ab. Seröse Zystadenome haben eine exzellente Prognose, ein Rezidiv ist bei einer vollständigen Tumorresektion in der Regel nicht zu erwarten. Durch eine operative Therapie können bei den solid-pseudopapillären Neoplasien exzellente Langzeitverläufe mit Heilungsraten > 95 % erreicht werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Arlix A, Bournet B, Otal P, Canevet G, Thevenot A, Kirzin S, Carrere N, Suc B, Moreau J, Escourrou J u. Buscail L (2011) Long-term clinical and imaging follow-up of nonoperated branch duct form of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 41(2): 295–301
Bae SY, Lee KT, Lee JH, Lee JK, Lee KH, Rhee JC (2011) Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas. Dig Liver Dis 44(3): 257–260
Bal MM, Deodhar K, Shrikhande S, Shukla P, Arya S, Ramadwar M (2013) Solid pseudopapillary tumor of the pancreas: ‚Experiences‘ and ‚Lessons‘ at a tertiary-care oncology center. Diagn Cytopathol 41(7): 599–606
Bassi C, Sarr MG, Lillemoe KD, Reber HA (2008) Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management. J Gastrointest Surg 12(4): 645–650
Bhanot P, Nealon WH, Walser EM, Bhutani MS, Tang WW, Logrono R (2005) Clinical, imaging, and cytopathological features of solid pseudopapillary tumor of the pancreas: a clinicopathologic study of three cases and review of the literature. Diagn Cytopathol 33(6): 421–428
Cai H, Zhou M, Hu Y, He H, Chen J, Tian W, Deng Y (2013) Solid-pseudopapillary neoplasms of the pancreas: clinical and pathological features of 33 cases. Surg Today 43(2): 148–154
Chari ST, Yadav D, Smyrk TC, DiMagno EP, Miller LJ, Raimondo M, Clain JE, Norton IA, Pearson RK, Petersen BT, Wiersema MJ, Farnell MB, Sarr MG (2002) Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 123(5): 1500–1507
Crippa S, Salvia R, Bassi C (2009) Development of ductal adenocarcinoma during follow-up of branch-duct IPMNs. Gut 58(6): 889–890
Crippa S, Salvia R, Warshaw AL, Dominguez I, Bassi C, Falconi M, Thayer SP, Zamboni G, Lauwers GY, Mino-Kenudson M, Capelli P, Pederzoli P, Castillo CF (2008) Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg 247(4): 571–579
Goh BK, Tan YM, Cheow PC, Chung AY, Chow PK, Wong WK, Ooi LL (2007) Solid pseudopapillary neoplasms of the pancreas: an updated experience. J Surg Oncol 95(8): 640–644
Guo N, Zhou QB, Chen RF, Zou SQ, Li ZH, Lin Q, Wang J, Chen JS (2011) Diagnosis and surgical treatment of solid pseudopapillary neoplasm of the pancreas: analysis of 24 cases. Can J Surg 54(6): 368–374
Honore C, Goere D, Dartigues P, Burtin P, Dumont F, Elias D (2012) Peritoneal carcinomatosis from solid pseudopapillary neoplasm (Frantz‘s tumour) of the pancreas treated with HIPEC. Anticancer Res 32(3): 1069–1073
Huang HL, Shih SC, Chang WH, Wang TE, Chen MJ, Chan YJ (2005) Solid-pseudopapillary tumor of the pancreas: clinical experience and literature review. World J Gastroenterol 11(9): 1403–1409
Kanter J, Wilson DB, Strasberg S (2009) Downsizing to resectability of a large solid and cystic papillary tumor of the pancreas by single-agent chemotherapy. J Pediatr Surg 44(10): e23–25
Kaufman SL, Reddick RL, Stiegel M, Wild RE, Thomas CG Jr (1986) Papillary cystic neoplasm of the pancreas: a curable pancreatic tumor. World J Surg 10(5): 851–859
Le Borgne J, de Calan L, Partensky C (1999) Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg 230(2): 152–161
Li Z, Zhang Z, Liu X, Hu W, Mai G, Zhang Y, Lu H, Zeng Y, Tian B (2010) Solid pseudopapillary tumor of the pancreas: the surgical procedures. Surg Today 41(1): 91–96
Mao C, Guvendi M, Domenico DR, Kim K, Thomford NR, Howard JM (1995) Papillary cystic and solid tumors of the pancreas: a pancreatic embryonic tumor? Studies of three cases and cumulative review of the world’s literature. Surgery 118(5): 821–828
Martin RC, Klimstra DS, Brennan MF, Conlon KC (2002) Solid-pseudopapillary tumor of the pancreas: a surgical enigma? Ann Surg Oncol 9(1): 35–40
Mimura T, Masuda A, Matsumoto I, Shiomi H, Yoshida S, Sugimoto M, Sanuki T, Yoshida M, Fujita T, Kutsumi H, Ku Y, Azuma T (2010) Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas. J Clin Gastroenterol 44(9): e224–229
Nakao A, Fernandez-Cruz L (2007) Pancreatic head resection with segmental duodenectomy: safety and long-term results. Ann Surg 246(6): 923–928; discussion 929–931
Niedergethmann M, Grützmann R, Hildenbrand R, Dittert D, Aramin N, Franz M, Dobrowolski F, Post S, Saeger HD (2008) Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience. World J Surg 32(10): 2253–2260
Papavramidis T, Papavramidis S (2005) Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature. J Am Coll Surg 200(6): 965–972
Rodriguez JR, Salvia R, Crippa S, Warshaw AL, Bassi C, Falconi M, Thayer SP, Lauwers GY, Capelli P, Mino-Kenudson M, Razo O, McGrath D, Pederzoli P, Fernandez-del Castillo C (2007) Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 133(1): 72–79; quiz 309–310
Sakorafas GH, Smyrniotis V, Reid-Lombardo KM, Sarr MG (2011) Primary pancreatic cystic neoplasms revisited: part II. Mucinous cystic neoplasms. Surg Oncol 20(2): e93–101
Salvia R, Crippa S, Falconi M, Bassi C, Guarise A, Scarpa A, Pederzoli P (2007) Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut 56(8): 1086–1090
Salvia R, Fernandez-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, Pederzoli P, Warshaw AL (2004) Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 239(5): 678–685; discussion 685–687
Sarr MG, Carpenter HA, Prabhakar LP, Orchard TF, Hughes S, van Heerden JA, DiMagno EP (2000) Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg 231(2): 205–212
Sarr MG, Murr M, Smyrk TC, Yeo CJ, Fernandez-del-Castillo C, Hawes RH, Freeny PC (2003) Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importance-current state-of-the-art and unanswered questions. J Gastrointest Surg 7(3): 417–428
Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239(6): 788–797; discussion 797–799
Sugiyama M, Izumisato Y, Abe N, Masaki T, Mori T, Atomi Y (2003) Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 90(10): 1244–1249
Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6(1–2): 17–32
Tanaka M, Fernandez-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, Kimura W, Levy P, Pitman MB, Schmidt CM, Shimizu M, Wolfgang CL, Yamaguchi K, Yamao K (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12(3): 183–197
Tang LH, Aydin H, Brennan MF, Klimstra DS (2005) Clinically aggressive solid pseudopapillary tumors of the pancreas: a report of two cases with components of undifferentiated carcinoma and a comparative clinicopathologic analysis of 34 conventional cases. Am J Surg Pathol 29(4): 512–519
Tipton SG, Smyrk TC, Sarr MG, Thompson GB (2006) Malignant potential of solid pseudopapillary neoplasm of the pancreas. Br J Surg 93(6): 733–737
Traverso LW, Peralta EA, Ryan JA Jr, Kozarek RA (1998) Intraductal neoplasms of the pancreas. Am J Surg 175(5): 426–432
Valsangkar NP, Morales-Oyarvide V, Thayer SP, Ferrone CR, Wargo JA, Warshaw AL, Fernandez-del Castillo C (2012) 851 resected cystic tumors of the pancreas: A 33-year experience at the Massachusetts General Hospital. Surgery 152(3 Suppl 1): S4–S12
Vollmer CM Jr, Dixon E, Grant DR (2003) Management of a solid pseudopapillary tumor of the pancreas with liver metastases. HPB (Oxford) 5(4): 264–267
Wada K, Kozarek RA, Traverso LW (2005) Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg 189(5): 632–636; discussion 637
Wang SE, Shyr YM, Chen TH, Su CH, Hwang TL, Jeng KS, Chen JH, Wu CW, Lui WY (2005) Comparison of resected and non-resected intraductal papillary mucinous neoplasms of the pancreas. World J Surg 29(12): 1650–1657
Zamboni G, Scarpa A, Bogina G, Iacono C, Bassi C, Talamini G, Sessa F, Capella C, Solcia E, Rickaert F, Mariuzzi GM, Klöppel G (1999) Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 23(4): 410–422
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gebauer, F., Izbicki, J., Yekebas, E. (2013). Langzeitverlauf nach Beobachtung und chirurgischer Therapie zystischer Pankreasneoplasien. In: Beger, H., et al. Erkrankungen des Pankreas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37964-2_60
Download citation
DOI: https://doi.org/10.1007/978-3-642-37964-2_60
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37963-5
Online ISBN: 978-3-642-37964-2
eBook Packages: Medicine (German Language)